Pharma is a safe market

Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.

Many rotor options for refrigerated microcentrifuge

The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.

Your partnering tool - step by step

Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!

Han leder nya Göteborgscentret

Professor Göran Landberg har utsetts till föreståndare för det nya Wallenbergcentret för molekylär och translationell medicin.

Swiss allergy therapy convinces

Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.

Cate Poulsen, Qiagen

Why are you going to Scanlab and Biotech Forum?

Multiple rotor options in refrigerated microcentrifuge

The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.

Young, bright and committed to labtech

Ghazal Voghoui recently bought her first apartment and finally settled in Stockholm again. Last year, she finished her law studies and she is relieved to be bac...

Kliniska studier på cancer mer positiva än verkligheten

Yngre, friskare och mer välutbildade patienter förbättrar resultaten när cancerbehandlingar testas i kliniska studier. Det menar två cancerläkare i en artikel s...

EU stoppar utdelning av Humiradata

EMA, som arbetar för ökad öppenhet, hindras av EU-domstolen att lämna ut rådata gällande kliniska studier.

820 miljoner till medicinsk forskning

359 projekt inom området för medicin får pengar från Vetenskapsrådet i år. I snitt kammar varje projekt hem 670 000 kronor i årets runda.

LEO Pharma - International Clinical Trial Manager

Faster sales but less profits for Probi

The probiotic company increases its turnover, and the net results are twice as large as last year.

Athera inleder fas I-studie

De första patienterna har behandlats i Atheras kliniska fas I-studie på hjärt-kärlsjukdomar.

Biotage is regrouping

The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.

EMA utreder data bakom godkännanden

Problem i mjukvara skapar tvivel runt godkännanden av generiska läkemedel.

Årets investerare: Nina Rawal

Drygt 20 procent av alla venture capital-investeringar inom life science-sektorn i Skandinavien kommer från Industrifonden under de tre senaste åren. Och chefen...

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

Vinnova ger miljoner till svensk-indiska projekt

Tillsammans med indiska Department of Biotechnology kommer Vinnova att satsa pengar på tuberkulosforskning. Vinnova räknar med att bidra med 16 miljoner till de...

Age essential when testing drugs

Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...

Medtech companies find new beam technique

The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.

Ten recieve the Venture Cup West Prize

At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.

A1M tar in pengar

Tar in 43,7 miljoner genom emission, planerar byte av börslista och publicerar ny tidsplan för verksamheten.

Vattenfall is firing with biomass

Vattenfall will provide Denmark with electricity by means of biomass.